Entero Healthcare Solutions Ltd (ENTERO) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- The company demonstrated a strong growth trajectory, with revenue increasing by 20.8% YoY, driven by a combination of organic growth and strategic acquisitions. On a like-to-like basis, adjusting for net margin contracts, revenue growth was even higher at 23.4% YoY.
- Significant margin expansion was a key highlight, with Gross Margin improving by 84 basis points YoY to 10.2% and EBITDA Margin reaching a milestone of 4.0%, up 69 basis points YoY. This was attributed to a better product mix, improved procurement, and operational efficiencies.
- The company has aggressively expanded its presence in the high-margin MedTech segment through five closed acquisitions and two more in the pipeline, which are expected to add over INR 1,000 crores in proforma revenue and positively impact overall margins by 50-75 basis points at the EBITDA level.
- Working capital management showed significant improvement, with net working capital days reducing to 63 days from 69 days a year ago. This was achieved through disciplined credit monitoring, enhanced collections, and data-driven inventory planning.
- The company's operational network continued to expand, now catering to over 85,000 retail pharmacies and 2,800+ hospitals across 490 districts, reinforcing its position as a comprehensive healthcare distribution platform in India.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.